New Zealand markets close in 34 minutes

ABBV Nov 2022 165.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
4.3000-0.2000 (-4.44%)
As of 02:29PM EDT. Market open.
Full screen
Previous close4.5000
Open4.4000
Bid0.0000
Ask0.0000
Strike165.00
Expiry date2022-11-18
Day's range4.0500 - 4.4000
Contract rangeN/A
Volume11
Open interestN/A
  • Motley Fool

    These 5 Top Stocks Are Set to Outperform in a Recession

    The Federal Reserve is grappling with elevated inflation by taking a hawkish stance and raising interest rates. Sprinkle in solid growth companies whose stock has fallen out of favor, yet for which the secular bull case remains intact.

  • Zacks

    AbbVie (ABBV) Gains But Lags Market: What You Should Know

    AbbVie (ABBV) closed the most recent trading day at $153.93, moving +0.08% from the previous trading session.

  • Motley Fool

    This Blockbuster Drug from AbbVie Is Closer to Another Major Indication

    The European Medicine Agency's Committee for Medicinal Products for Human Use (CHMP) recently adopted a positive opinion that recommended the approval of AbbVie's (NYSE: ABBV) Rinvoq for what would be its fifth indication in that market. This would be to treat patients with moderate-to-severe ulcerative colitis who had an inadequate response to conventional therapies or biologic agents. A decision for Rinvoq as a treatment for moderate-to-severe ulcerative colitis patients from the European Commission is expected in the third quarter of this year.